Tag Archives: Rapid QIAstat-Dx Panel

FDA Clears QIAGEN’s Rapid QIAstat-Dx Panel for Meningitis and Encephalitis Diagnosis, Expanding Syndromic Test Portfolio

Posted on 4, November 2024 by EuropaWire PR Editor

(IN BRIEF) QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of critical CNS infections like meningitis and encephalitis. This panel, the fourth QIAstat-Dx test approved in the U.S. in 2024, uses real-time PCR to … Read the full press release →

Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology

Tagged Encephalitis Diagnosis, FDA, Fernando Beils, Healthcare, meningitis, QIAGEN, Rapid QIAstat-Dx Panel, safety, Syndromic Test